πŸ‡ΊπŸ‡Έ FDA
Patent

US 8980859

Aegyptin and uses thereof

granted A61KA61K38/00A61K38/49

Quick answer

US patent 8980859 (Aegyptin and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K38/49, A61K39/0003, A61K45/06